Skip to main content
Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc. — Investor Relations & Filings

Ticker · XENE ISIN · CA98420N1050 LEI · 549300XV44Q9Z1MIPQ03 US Manufacturing
Filings indexed 746 across all filing types
Latest filing 2023-02-14 Major Shareholding Noti…
Country CA Canada
Listing US XENE

About Xenon Pharmaceuticals Inc.

https://www.xenon-pharma.com/

Xenon Pharmaceuticals Inc. is a neuroscience-focused biopharmaceutical company dedicated to the discovery, clinical development, and commercialization of therapeutics for neurological and psychiatric disorders. The company leverages its expertise in human genetics and a deep understanding of ion channel biology to develop medicines that modulate ion channels, targeting the central and peripheral nervous systems. Its late-stage pipeline includes azetukalner, an investigational candidate being developed for the treatment of epilepsy and depression.

Recent filings

Filing Released Lang Actions
AMENDMENT NO. 13 TO THE SCHEDULE 13G
Major Shareholding Notification
2023-02-14 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-02-10 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-02-09 English
FORM 4 SUBMISSION
Director's Dealing
2022-12-13 English
FORM 4 SUBMISSION
Director's Dealing
2022-11-29 English
FORM 4 SUBMISSION
Director's Dealing
2022-11-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.